SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-324990
Filing Date
2019-12-27
Accepted
2019-12-27 17:28:28
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d855727ds3.htm S-3 436797
2 EX-1.2 d855727dex12.htm EX-1.2 175665
3 EX-4.2 d855727dex42.htm EX-4.2 308770
4 EX-4.4 d855727dex44.htm EX-4.4 103811
5 EX-4.5 d855727dex45.htm EX-4.5 105766
6 EX-4.6 d855727dex46.htm EX-4.6 93940
7 EX-5.1 d855727dex51.htm EX-5.1 27468
8 EX-23.1 d855727dex231.htm EX-23.1 1822
9 GRAPHIC g855727dsp_184.gif GRAPHIC 1081
10 GRAPHIC g855727g10q66.jpg GRAPHIC 86617
11 GRAPHIC g855727g82y45.jpg GRAPHIC 24891
  Complete submission text file 0001193125-19-324990.txt   1410674
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235735 | Film No.: 191314295
SIC: 2834 Pharmaceutical Preparations